Research on exercise methods for pectus excavatum (PE) is limited, highlighting the need for further studies. This study investigated the effects of Schroth-based exercise therapy combined with vacuum treatment in 35 adolescents with PE, divided into a vacuum + exercise group (n=19) and a vacuum-only group (n=16). Outcomes included deformity severity, sagittal posture, thoracic cage and spinal mobility, muscle endurance, and quality of life. The combination therapy significantly improved sagittal spinal posture (craniovertebral, thoracic, thoracolumbar, lumbar angles) and deformity-specific quality of life (Nuss Questionnaire scores) compared to vacuum-only treatment.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
35
Due to the limited research on exercise approaches for pectus excavatum, further investigation in this field is needed. This study aims to explore the impact of Schroth-based exercise therapy on adolescents with pectus excavatum.
Hacettepe Uuniversity
Ankara, altındağ, Turkey (Türkiye)
Primary Outcome Measure 1: Deformity Severity
Primary Outcome Measure 1: Deformity Severity Measurement: Anthropometric Index (cm) Details: Repeated, in cm. Time frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment
Time frame: 12 weeks
Primary Outcome Measure 2: Sagittal Spinal Posture
Primary Outcome Measure 2: Sagittal Spinal Posture Measurement: Lateral Photos (°) Details: In degrees Time Frame:The assessment will be conducted during the first week of treatment and 12 weeks after treatment
Time frame: 12 weeks
Primary Outcome Measure 3: Disease-Specific QoL
Primary Outcome Measure 3: Disease-Specific QoL Measurement: Nuss Questionnaire (1-4) Details: Higher = better Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment
Time frame: 12 weeks
Primary Outcome Measure 4: General QoL
Primary Outcome Measure 4: General QoL Measurement: PedsQL (0-100) Details: Higher = better Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment
Time frame: 12 weeks
Secondary Outcome Measure 1: Thoracic Cage Mobility
Secondary Outcome Measure 1: Thoracic Cage Mobility Measurement: Chest Circumference (cm) Details: In cm Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment
Time frame: 12 weeks
Secondary Outcome Measure 2: Spinal Mobility
Secondary Outcome Measure 2: Spinal Mobility Measurement: Sit-and-Reach (cm) Details: Highest value Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment
Time frame: 12 weeks
Secondary Outcome Measure 3: Lumbar Mobility
Secondary Outcome Measure 3: Lumbar Mobility - Measurement: Modified Schober (cm) Details: Difference in cm Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment
Time frame: 12 weeks
Secondary Outcome Measure 4: Muscle Endurance (Sit-Ups)
Secondary Outcome Measure 4: Muscle Endurance (Sit-Ups) Measurement: Sit-Up (reps/30s) Details: Repetitions Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment
Time frame: 12 weeks
Secondary Outcome Measure 5: Muscle Endurance (Lateral Bridge)
Secondary Outcome Measure 5: Muscle Endurance (Lateral Bridge) Measurement: Lateral Bridge (s) Details: Duration Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.